Impact of coronavirus disease 2019 pandemic on breast cancer screening and detection of high-risk mammographic findings
Rev. Assoc. Med. Bras. (1992, Impr.)
; 68(6): 842-846, June 2022. tab, graf
Article
em En
|
LILACS-Express
| LILACS
| ID: biblio-1387170
Biblioteca responsável:
BR1.1
ABSTRACT
SUMMARY OBJECTIVE:
The coronavirus disease 2019 pandemic has disrupted cancer screening worldwide. This study aims to analyze the changes in the rates of screening mammograms and BIRADS 4 or 5 mammograms during the coronavirus disease 2019 pandemic in the opportunistic scenario.METHODS:
We integrated three different public databases from the state of São Paulo, Brazil, to obtain the rate of screening mammograms per 1,000, and the rate of BIRADS 4 or 5 mammograms per 100,000 women aged from 50 to 69 years in the years from January 2017 to December 2020.RESULTS:
The mean monthly screening mammograms decreased from 14.8/1,000 in 2019 to 9.25/1,000 in 2020, with the lowest rates being recorded in May 2020 (3.1/1,000). The mean monthly high-risk mammograms decreased from 12.8/100,000 in 2019 to 9.1/100,000 in 2020, with the lowest rates being recorded in April 2020 (4.3/100,000).CONCLUSIONS:
Coronavirus disease 2019 pandemic significantly decreased mammography screening in an opportunistic scenario, a warning sign for decreasing diagnosis of breast cancer in early stages, and increasing advanced stage diagnosis and mortality in the future.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
/
Screening_studies
Idioma:
En
Revista:
Rev. Assoc. Med. Bras. (1992, Impr.)
Ano de publicação:
2022
Tipo de documento:
Article
/
Project document